Abstract
Brain tumors are the second-most common neoplasm in children, and the most common solid tumor. Glial tumors comprise about 40% of the primary brain tumors that occur in children. Slightly more than 50% of the glial neoplasms are low-grade tumors, and these are almost all pilocytic astrocytom as that occur in the cerebellum, optic apparatus, and diencephalon. As with adults, HGG in children may occur anywhere in the central nervous system (CNS). However, in children, there tends to be a greater percentage of tumors that are localized in the deep gray matter, cerebellum, and especially within the brainstem. Despite technological advances in neuroimaging, improvements in surgical techniques, advances in radiotherapy, and the proliferation of new anti-neoplastic agents, the prognosis for survival of high-grade glioma in children has only improved marginally over the past several decades. Although the prognosis for survival of supratentorial high-grade glioma is not as ominous in children as in adults, this survival advantage may be in part a result of stronger constitution of children as well as differences in the molecular genetic substrate of the neoplasm.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Leviton A. Principles of Epidemiology. In: Cohen ME, Duffner PK, eds. Brain Tumors in Children. Principles of Diagnosis and Treatment 2nd Edition. Raven Press: New York, 1994:27–49.
Bruce H. Cohen and James Garvin: Brain Tumors. In: Rudolph, Hoffman, Rudolph, eds. Roudolph’es Pediatrics, 21st Edition., Appleton & Lange: Stamford, 2002.
Fischbein NJ, Prados MD, Wara W, Russo C, Edwards MSB, Barkovich AJ. Radiologic classification of brain stem tumors: correlation of magnetic resonance imaging appearance and clinical outcome. Pediatr Neurosurg 1996;24:9–23.
Zimmerman RA. Neuroimaging of pediatric brain stem diseases other than brain stem glioma. Pediatr Neurosurg 1996;25:83–92.
Packer RJ, Zimmerman RA, Luerssen TG, Sutton LN, Bilaniuk LT, Bruce DA, Schut L. Brainstem gliomas of childhood: magnetic resonance imaging. Neurology 1985;35:397–401.
Panitch ES, Berg BO. Brainstem tumors of childhood and adolescence. Am J Dis Child 1970;119:465–467.
Albright AL, Guthkelch AN, Packer RJ, et al. Prognostic factors in pediatric brain-stem Gliomas. J Neurosurg 1986;65:751–755.
Packer RJ. Brain Tumors in Children (Neurological Review). Arch Neurol 1999;56:421–425.
Rickert CH, Ströter R, Kaatsch P et al. Pediatric high-grade astrocytomas show chromosomal imbalances distinct from adult cases. Am J Pathol 2001;158:1525–1532.
Principles of Clinical Diagnosis. In:Cohen ME, Duffner PK, eds. Brain Tumors in Children. Principles of Diagnosis and Treatment. Raven Press: New York, 1984:9–21.
Dohrmann GJ, Farwell JR, Flannery JY. Glioblastoma multiforme in children. J Neurosurg 1976;44:442–448.
Wisoff JH, Boyett JM, Berger MS, et al. Current neurosurgical management and the impact of the extent of resection in the treatment of malignant gliomas of childhood: a report of the Children’s Cancer Group trial no. CCG-945. J Neruosurg 1998;89(1):52–59.
Finlay JL, Wisoff JH. The impact of extent of resection in the management of malignant gliomas of childhood. Shild Nerv Sys 1999;15(11-12):786–788.
Bloom HJ, Glees J, Bell J, Ashley SE, Gorman C. The treatment and long-term prognosis of children with intracranial tumors: a study of 610 cases, 1950-1981. [erratum appears in]. Int J Radiat Oncol Biol Phys 1990;18(4):723–45; erratum, Int J Radiat Oncol Biol Phys 1990;19(3):829.
Marchese MJ. Chang CH. Malignant astrocytic gliomas in children. Cancer 1990;65(12):2771–2778
Dropcho EJ, Wisoff JH, Walker RW, Allen JC. Supratentorial malignant gliomas in childhood: a review of fifty cases. Ann Neurol 1987;22(3):355–364.
Bloom HJ. Intracranial tumors: response and resistance to therapeutic endeavors, 1970-1980. Int J Radiat Oncol Biol Phys 1982;8(7):1083–1113
Sheline GE. Radiation therapy of brain tumors. Cancer 1977;39(2):873–81.
Packer RJ, Vezina G, Nicholson HS, Chadduck WM. Childhood and Adolescent Gliomas. In: Berger MS, Wilson CD, eds. The Gliomas. Philadelphia: Saunders, 1999;689-701.
Sposto R, Ertel IM, Jenkin RDT, et al. The effectiveness of chemotherapy for treatment of high-grade astrocytoma in children: results of a randomize trial. J Neurooncol 1989;7:165–171.
Finlay J, Boyett J, Yates A, et al. Randomized phase III trial in childhood high-grade astrocytomas comparing vincristine, lomustine and prednisone with eight-drug-in-one-day regimen. J Clin Oncol 1995;13:112–123.
Grovas AC, Boyett JM, Lindsley K, Rosenblum M, Yates AJ, Finlay JL. Regimen-related toxicity of myeloablative chemotherapy with BCNU, thiotepa, and etoposide followed by autologous stem cell rescue for children with newly diagnosed glioblastoma multiforme: report from the Children’es Cancer Group. Med Pediatr Oncol 1999;33(2):83–87.
Finlay JL, Goldman S, Wong MC, et al. Pilot study of high-dose thiotepa and etoposide with autologous bone marrow rescue in children and young adults with recurrent CNS tumors. J Clin Oncol 1996;14:2495–2503.
Massimino M, Gandola L, Luksch R, et al. Sequential chemotherapy, high-dose thiotepa, circulating progenitor cell rescue, and radiotherapy for childhood high-grade glioma. Neuro Oncol 2005;7(1):41–48.
Stupp R, Mason WP, van den Bent MJ, et al. European Organization for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups. National Cancer Institute of Canada Clinical Trials Group. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005;352(10):987–996
Lashford LS, Thiesse P, Jouvet A, et al. Temozolomide in malignant gliomas of childhood: A United Kingdom Children’es Cancer Study Group and French Society for Pediatric Oncology Intragroup Study. J Clin Oncol 2002;20:4684–4691.
Verschuur AC, Grill J, Lelouch-Tubiana A, Couanet D, Kalifa C, Vassal G. Temozolomide in paediatric highgrade glioma: a key for combination therapy? Br J Cancer 2004;91:425–429.
Farwell JR, Dohrmann GJ, Flannery JT. Central nervous system tumors in children. Cancer 1977;40:3123–3132.
Donahue B, Allen J, Siffert J, Rosovsky M, Pinto R. Patterns of recurrence in brain stem gliomas: evidence for craniospinal dissemination. Int J Radiat Oncol Biol Phys 1998;40(3):677–680.
Packer RJ, Allen J, Nielsen S, Petito C, Deck M, Jereb B. Brainstem glioma: clinical manifestations of meningeal gliomatosis. Ann Neuro 1983;14:177–182.
Motoyama Y, Ogi S, Nabeshima S. Pontine glioblastoma multiforme initially presenting with leptomeningeal gliomatosis. Neurol Med Chir 2002;42(7):309–313.
Packer RJ. Brain tumors in children. Arch Neurol 1999;56(4):421–425.
Cartmill M, Punt J. Brain stem gliomas, the role of biopsy. Br J Neurosurg 1997; 11:177.
Albright AL. Diffuse brainstem tumors. When is a biopsy necessary? Pediatric Neurosurg 1996;24:252–255.
Albright AL, Packer RJ, Zimmerman R, et al. Magnetic resonance scans should replace biopsies for the diagnosis of diffuse brain stem Gliomas: a report from the Children’es Cancer Group. Neurosurgery 1993;33:1026–1030.
Epstein F. McCleary EL. Intrinsic brain-stem tumors of childhood: surgical indications J Neurosurg 1986;64:11–15.
Cohen BH, Packer RJ, Siegel KR, et al. Brain tumors in children under two years: Treatment, survival and long-term prognosis. Pediatr Neurosurg 1993;19(4):171–179.
Bruce H. Cohen and James Garvin: Brain Tumors. In: Rudolph, Hoffman, Rudolph, eds. Roudolph’es Pediat-rics, 21th Edition. Stamford: Appleton & Lange, 2002.
Packer RJ, Nicholson SH, Venzina FL, Johnson DL. Brainstem gliomas. Neurosurg Clini N Am 1992;3:863–880.
Packer RJ, Boyett JM, Zimmerman RA, et al. Outcome of children with brain stem gliomas aftertreatment with 7800 cGy of hyperfractionated radiotheapy. Cancer 1994;74:1827–1834.
Freeman CR, Krischer J, Sanford RA, et al. Hyperfractionated radiotherapy in brainstem tumor: results of a Pediatric Oncology Group Study. Int J Radiat Oncol Biol Phys 1998;15:311–318.
Packer RJ, Boyett JM, Zimmerman RA et al. Hyperfractionated radiation therapy (72 Gy) for children with brain stem gliomas: A Children’es Cancer Group phase I/II trial. Cancer 1993;72:1414–1421.
Packer RJ, Boyett JM, Zimmerman RA, et al. Brain stem gliomas of childhood: outcome after treatment with 7800 cGy or hyperfractionated radiotherapy: a Children’es Cancer Group phase I/II trial. Cancer 1994;74:1827–1834.
Jennings MT, Freeman ML, Murray MJ. Strategies in the treatment of diffuse pontine gliomas: the therapeutic role of hyperfractionated radiotherapy and chemotherapy. J Neurooncol 1996;28:207–222.
Lashford LS, Thiesse P, Jouvet A, et al. Temozolomide in malignant gliomas of childhood: A United Kingdom Children’s Cancer Study Group and French Society for Pediatric Oncology Intergroup Study. J Clin Oncol 2002;20(24):4684–4691.
Freeman CR, Kepner J, Kun LE, et al. A detrimental effect of a combined chemotherapy-radiotherapy approach in children with diffuse intrinsic brain stem gliomas? Int J Rad Oncol Biol Phys 2000;47(3):561–564.
Allen J, Siffert J, Donahue B, et al. A phase I/II study of carboplatin combined with hyperfractionated radiotherapy for brainstem gliomas. Cancer 1999;86(6):1064–1069.
Kaplan AM, Albright AL, Zimmerman RA, et al. Brainstem gliomas in children. A Children’es Cancer Group review of 119 cases. Pediatr Neurosurg 1996;24(4):185–192.
Marcus K., Dutton S., Barnes P., et al. A phase I trial of etandizole and hyperfractionated radiotherapy in children with diffuse brainstem glioma. Intern J Radiat Oncol Biol Physics 2003;55:1182–1185.
Chamberlain MC. Recurrent brainstem gliomas treated with oral VP-16. J Neurooncol 1993;15(2):133–139.
Jennings MT, Sposto R, Boyett JM, et al. Preradiation chemotherapy in primary high-risk brainstem tumors: phase II study CCG-9941 of the Children’es Cancer Group. J Clin Oncol 2002;20:3431–3437.
Broniscer A, Leite C, Lanchote V, Machado T, Cristofani L, and the Brainstem Glioma Cooperative Group. Radiation therapy and high-dose tamoxifen in the treatment of patients with diffuse brainstem gliomas: results of a Brazilian cooperative study. J Clin Oncol 2000;18:1246–1253.
Dunkel IJ, Finlay JL. High-dose chemotherapy with autologous stem cell rescue for brain tumors. Crit Rev Oncol Hematol 2002;41(2):197–204.
Pollack IF, Hoffman HJ, Jumphreys RP, Becker L. The longterm outcome after surgical treatment of dorsally exophytic brain-stem gliomas. J Neurosurg 1993;78:859–863.
Pollack IF, Pang D, Albright AL. The long-term outcome in children with late onset aqueduct stenosis resulting from benign intrinsic tectal tumors. J Neurosurg 1994;80:681–688.
Hoffman HJ. Dorsally exophyic brain stem tumors and midbrain tumors. Pediatr Neurosurg 1996;24:256–262.
Hughes RAC. Neurological complications of neurofibromatosis 1. In: Huson SM, Hughes RAC, eds. The neurofibromatoses. A pathogenetic and clinical overview. London: Chapman & Hall Medical, 1994;204-222.
Bilaniuk LT, Molloy PT, Zimmerman RA, et al. Neurofibromatosis type 1: brain stem tumours. Neuroradiology 1997;39(9):642–653.
Pollack IF, Shultz B, Mulvihill JJ. The management of brainstem gliomas in patients with neurofibromatosis 1. Neurology 1996;46:1652–1660.
Rosser T, Packer RJ. Intracranial neoplasms in children with neurofibromatosis. J Child Neurol 2002;17:630–637.
Allen JC, Aviner S, Yates AJ, et al. Treatment of high-grade spinal cord astrocytoma of childhood with “e8-in-1”e chemotherapy and radiotherapy: apilot study of CCG-945. Children’es Cancer Group. J Neurosurg 1998;88(2):215–220.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Humana Press Inc., Totowa, NJ
About this chapter
Cite this chapter
Cohen, B.H. (2007). Pediatric High-Grade Glioma. In: Barnett, G.H. (eds) High-Grade Gliomas. Current Clinical Oncology. Humana Press. https://doi.org/10.1007/978-1-59745-185-7_3
Download citation
DOI: https://doi.org/10.1007/978-1-59745-185-7_3
Publisher Name: Humana Press
Print ISBN: 978-1-58829-511-8
Online ISBN: 978-1-59745-185-7
eBook Packages: MedicineMedicine (R0)